Pharma-Bio Serv (PBSV) Short-term Investments (2010 - 2026)

Pharma-Bio Serv's Short-term Investments history runs 12 years deep, the most recent figure standing at $6.7 million for Q2 2026.

• Quarterly Short-term Investments fell 19.64% year-over-year to $6.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $6.7 million (down 19.64% YoY) and the FY2025 annual result came in at $7.5 million, up 25.05% from the prior year.
• Short-term Investments was $6.7 million for Q2 2026 at Pharma-Bio Serv, up from $4.8 million in the prior quarter.
• Across five years, Short-term Investments topped out at $11.7 million in Q3 2023 and bottomed at $4.5 million in Q4 2023.
• A 4-year average of $7.2 million and a median of $6.7 million in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments soared 80.98% — and 2025, when it tumbled 45.89%.
• Pharma-Bio Serv's Short-term Investments stood at $4.5 million in 2023, then jumped by 31.93% to $6.0 million in 2024, then grew by 25.05% to $7.5 million in 2025, then declined by 10.63% to $6.7 million in 2026.
• Business Quant data shows PBSV's Short-term Investments at $6.7 million in Q2 2026, $4.8 million in Q1 2026, and $7.5 million in Q4 2025.